ORXOF
Price:
$1.12
Market Cap:
$413.80M
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microv...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-04-11
Stock Exchange
PNK
Ticker
ORXOF
According to Orexo AB (publ)’s latest financial reports and current stock price. The company's current ROE is -301.91%. This represents a change of 10.04% compared to the average of -2.98% of the last 4 quarters.
The mean historical ROE of Orexo AB (publ) over the last ten years is -20.56%. The current -301.91% ROE has changed 1.37% with respect to the historical average. Over the past ten years (40 quarters), ORXOF's ROE was at its highest in in the September 2024 quarter at 154.04%. The ROE was at its lowest in in the June 2024 quarter at -148.35%.
Average
-20.56%
Median
-13.60%
Minimum
-91.59%
Maximum
31.02%
Discovering the peaks and valleys of Orexo AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 542.92%
Maximum Annual ROE = 31.02%
Minimum Annual Increase = -148.72%
Minimum Annual ROE = -91.59%
Year | ROE | Change |
---|---|---|
2023 | -21.50% | -76.53% |
2022 | -91.59% | 43.27% |
2021 | -63.93% | 323.05% |
2020 | -15.11% | -148.72% |
2019 | 31.02% | 7.08% |
2018 | 28.96% | 310.87% |
2017 | 7.05% | -24.57% |
2016 | 9.35% | -112.02% |
2015 | -77.75% | 542.92% |
2014 | -12.09% | -87.40% |
The current ROE of Orexo AB (publ) (ORXOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-59.01%
5-year avg
-32.22%
10-year avg
-20.56%
Orexo AB (publ)’s ROE is less than Genomma Lab Internacional, S.A.B. de C.V. (22.07%), less than Hypera S.A. (14.51%), greater than Sumitomo Pharma Co., Ltd. (-97.03%), less than Indivior PLC (4.22%), greater than Elanco Animal Health Incorporated (-20.61%), less than SIGA Technologies, Inc. (51.39%), less than Esperion Therapeutics, Inc. (26.20%), greater than Catalent, Inc. (-26.99%),
Company | ROE | Market cap |
---|---|---|
22.07% | $1.15B | |
14.51% | $2.44B | |
-97.03% | $1.71B | |
4.22% | $3.01B | |
-20.61% | $6.21B | |
51.39% | $499.59M | |
26.20% | $392.45M | |
-26.99% | $10.65B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orexo AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orexo AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Orexo AB (publ)'s ROE?
How is the ROE calculated for Orexo AB (publ) (ORXOF)?
What is the highest ROE for Orexo AB (publ) (ORXOF)?
What is the 3-year average ROE for Orexo AB (publ) (ORXOF)?
What is the 5-year average ROE for Orexo AB (publ) (ORXOF)?
How does the current ROE for Orexo AB (publ) (ORXOF) compare to its historical average?